Market Recap — July 27, 2026
Recap of insider activity, SEC filings, and market-moving news for July 27, 2026.
Last generated Jul 28, 2026, 10:48 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Luxfer to Go Private in $17.37/Share All-Cash Deal with Wynnchurch Capital
Luxfer to Be Acquired for $17.37/Share in All-Cash Deal
argenx to Acquire Forte Biosciences for $77/Share in $2.2B All-Cash Deal
argenx to Acquire Forte Biosciences for $77/Share in $2.2B Deal, 86% Premium
Vestand Loses Nasdaq Listing, Falls to OTC Pink After Failed Appeal
J&J Reaches Proposed Settlement in Ovarian Talc Litigation
Goliath Film & Media 10-K: Going Concern Warning, Ineffective Controls, and 38M Share Overhang
Curium Nears $7B Lantheus Buyout at $114.50/Share
SpaceX Sheds $1.2 Trillion in Market Cap, Stock Falls to $113.50 Ahead of Lock-Up Expiration
Vivakor Converts $2.25M Debt to 2.45M Shares; Revenue Run-Rate Tops $1B
Nasdaq Delisting Looms for Nexalin Technology as Company Files Appeal
iPower Puts $40M in Deeply Dilutive Stock Issuances to a Vote, Including a Related-Party Buyout
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
One Day After Mapfre's $1.54B Buyout, 10% Owner SRB Corp Sells $4M in Safety Insurance at $103.08
CEO Jennifer Lloyd Unloads $936K of Power Integrations Stock
10% Owner Swaps $1M Debt for Equity, Sells $66K as Going-Concern Fears Mount
10% Owner HRT Financial Buys $26K After Selling $12K — Net Accumulation Continues
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Luxfer to Go Private in $17.37/Share All-Cash Deal with Wynnchurch Capital
Luxfer to Be Acquired for $17.37/Share in All-Cash Deal
argenx to Acquire Forte Biosciences for $77/Share in $2.2B All-Cash Deal
argenx to Acquire Forte Biosciences for $77/Share in $2.2B Deal, 86% Premium
Vestand Loses Nasdaq Listing, Falls to OTC Pink After Failed Appeal
J&J Reaches Proposed Settlement in Ovarian Talc Litigation
Curium Nears $7B Lantheus Buyout at $114.50/Share
SpaceX Sheds $1.2 Trillion in Market Cap, Stock Falls to $113.50 Ahead of Lock-Up Expiration
Vivakor Converts $2.25M Debt to 2.45M Shares; Revenue Run-Rate Tops $1B
Nasdaq Delisting Looms for Nexalin Technology as Company Files Appeal
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.